|
|
| Line 1: |
Line 1: |
| − | <span style="font-size: 140%;">The administration of hyperbaric oxygen did not improve outcome in carbon monoxide poisoning without a history of loss of consciousness. </span>
| |
| | | | |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Clinical Bottom Line: </span>'''</span> | + | <span style="font-size: 140%;">The administration of hyperbaric oxygen did not improve outcome in carbon monoxide poisoning without a history of loss of consciousness.</span> |
| − | <span style="font-family: 'Times New Roman'; font-size: 120%;">1. No evidence for benefit of hyperbaric oxygen in the treatment of carbon monoxide poisoning without loss of consciousness. </span>
| |
| − | <span style="font-family: 'Times New Roman'; font-size: 120%;">2. No evidence of benefit of two HBO sessions over a single session for patients with a history of loss of consciousness. </span>
| |
| | | | |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Appraised by:</span>'''<span style="font-family: 'Times New Roman';"> Mike Bennett, Dept of Diving and Hyperbaric Medicine, Prince of Wales Hospital </span></span> | + | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Clinical Bottom Line:</span>'''</span> <span style="font-family: 'Times New Roman'; font-size: 120%;">1. No evidence for benefit of hyperbaric oxygen in the treatment of carbon monoxide poisoning without loss of consciousness. </span> <span style="font-family: 'Times New Roman'; font-size: 120%;">2. No evidence of benefit of two HBO sessions over a single session for patients with a history of loss of consciousness.</span> |
| − | <span style="font-family: 'Times New Roman'; font-size: 120%;">Sydney, Saturday, 20 February 1999 </span> | |
| | | | |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Clinical Scenario:</span>'''<span style="font-family: 'Times New Roman';"> A patient presented with carbon monoxide poisoning for treatment. </span></span> | + | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Appraised by:</span>'''<span style="font-family: 'Times New Roman';">Mike Bennett, Dept of Diving and Hyperbaric Medicine, Prince of Wales Hospital</span></span> <span style="font-family: 'Times New Roman'; font-size: 120%;">Sydney, Saturday, 20 February 1999</span> |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Three-part Question:</span>'''<span style="font-family: 'Times New Roman';"> In patients with mild and moderate carbon monoxide poisoning, does the administration of hyperbaric oxygen, compared to normobaric oxygen, result in any reduction in the rate of neurological impairment one month later? </span></span>
| |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Search Terms:</span>'''<span style="font-family: 'Times New Roman';"> hyperbaric oxygenation, carbon monoxide </span></span> | |
| | | | |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">The Study: </span>'''</span> | + | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Clinical Scenario:</span>'''<span style="font-family: 'Times New Roman';">A patient presented with carbon monoxide poisoning for treatment.</span></span> <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Three-part Question:</span>'''<span style="font-family: 'Times New Roman';">In patients with mild and moderate carbon monoxide poisoning, does the administration of hyperbaric oxygen, compared to normobaric oxygen, result in any reduction in the rate of neurological impairment one month later?</span></span> <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Search Terms:</span>'''<span style="font-family: 'Times New Roman';">hyperbaric oxygenation, carbon monoxide</span></span> |
| − | <span style="font-family: 'Times New Roman'; font-size: 120%;">Non-blinded concealed randomised controlled trial with intention-to-treat. </span> | |
| − | <span style="font-family: 'Times New Roman'; font-size: 120%;">Adult patients exposed to carbon monoxide and presenting for treatment within 12 hours of exposure. Minimum carboxyhaemoglobin levels of 10% in smokers and 5% in non-smokers. </span>
| |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Control groups</span>'''<span style="font-family: 'Times New Roman';"> '''1.'''(N = 170; 148 analysed): Patients with no history of unconsciousness. Normobaric 100% oxygen for six hours. '''2.'''(N = 145; 127 analysed): Patients with a history of loss of consciousness. Oxygen at 2ATA for two hours then 1ATA for 4 hours. </span></span> | |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Experimental groups 1.</span>'''<span style="font-family: 'Times New Roman';">(N = 173; 159 analysed): Patients with no history of unconsciousness. Oxygen at 2ATA for two hours then 1ATA for 4 hours. '''2.'''(N = 141; 125 analysed) Patients with a history of loss of consciousness. Oxygen at 2ATA for two hours, then 1ATA for 4 hours, then 2ATA for a further two hours at 12 hours after the first HBO. </span></span> | |
| | | | |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">The Evidence:1. </span>'''</span> | + | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">The Study:</span>'''</span> <span style="font-family: 'Times New Roman'; font-size: 120%;">Non-blinded concealed randomised controlled trial with intention-to-treat. </span> <span style="font-family: 'Times New Roman'; font-size: 120%;">Adult patients exposed to carbon monoxide and presenting for treatment within 12 hours of exposure. Minimum carboxyhaemoglobin levels of 10% in smokers and 5% in non-smokers. </span> <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Control groups</span>'''<span style="font-family: 'Times New Roman';">'''1.'''(N = 170; 148 analysed): Patients with no history of unconsciousness. Normobaric 100% oxygen for six hours. '''2.'''(N = 145; 127 analysed): Patients with a history of loss of consciousness. Oxygen at 2ATA for two hours then 1ATA for 4 hours.</span></span> <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Experimental groups 1.</span>'''<span style="font-family: 'Times New Roman';">(N = 173; 159 analysed): Patients with no history of unconsciousness. Oxygen at 2ATA for two hours then 1ATA for 4 hours. '''2.'''(N = 141; 125 analysed) Patients with a history of loss of consciousness. Oxygen at 2ATA for two hours, then 1ATA for 4 hours, then 2ATA for a further two hours at 12 hours after the first HBO.</span></span> |
| | | | |
| − | {|
| + | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">The Evidence:1.</span>'''</span> |
| − | | <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Outcome </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Time to Outcome </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Control groups </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Hyperbaric groups </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Relative risk reduction </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Absolute risk reduction </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style="font-family: 'Times New Roman';">NNT </span>'''</span></span>
| + | |
| | + | {| |
| | |- | | |- |
| − | | <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Recovered </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">1 month </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">0.662 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">0.679 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-3% </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-0.017 </span></span> || <span style'''"display: block; text-align: center;"><span style="display: block; font-family: 'times new roman'; text-align: center;">-59 </span></span> | + | | <span><span>'''<span>Outcome</span>'''</span></span> |
| | + | | <span><span>'''<span>Time to Outcome</span>'''</span></span> |
| | + | | <span><span>'''<span>Control groups</span>'''</span></span> |
| | + | | <span><span>'''<span>Hyperbaric groups</span>'''</span></span> |
| | + | | <span><span>'''<span>Relative risk reduction</span>'''</span></span> |
| | + | | <span><span>'''<span>Absolute risk reduction</span>'''</span></span> |
| | + | | <span><span>'''<span style="font-family: 'Times New Roman';">NNT</span>'''</span></span> |
| | |- | | |- |
| − | | <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">95% CI: </span>'''</span></span> || || || || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-18% to 13% </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-0.122 to 0.088 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">NNT ''' 11 to INF NNH = 8 to INF </span></span> | + | | <span><span>'''<span>Recovered</span>'''</span></span> |
| | + | | <span><span>1 month</span></span> |
| | + | | <span><span>0.662</span></span> |
| | + | | <span><span>0.679</span></span> |
| | + | | <span><span>-3%</span></span> |
| | + | | <span><span>-0.017</span></span> |
| | + | | <span><span style="display: block; font-family: 'times new roman'; text-align: center;">-59</span></span> |
| | |- | | |- |
| − | | <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Persistent symptom </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">1 month </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">0.338 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">0.321 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">5% </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">0.017 </span></span> || <span style'''"display: block; text-align: center;"><span style="display: block; font-family: 'times new roman'; text-align: center;">59 </span></span> | + | | <span><span>'''<span>95% CI:</span>'''</span></span> |
| | + | | |
| | + | | |
| | + | | |
| | + | | <span><span>-18% to 13%</span></span> |
| | + | | <span><span>-0.122 to 0.088</span></span> |
| | + | | <span><span>NNT '''11 to INF NNH = 8 to INF'''</span></span> |
| | |- | | |- |
| − | | <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">95% CI: </span>'''</span></span> || || || || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-26% to 36% </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-0.088 to 0.122 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">NNT ''' 8 to INF NNH = 11 to INF </span></span> | + | | <span><span>'''<span>Persistent symptom</span>'''</span></span> |
| | + | | <span><span>1 month</span></span> |
| | + | | <span><span>0.338</span></span> |
| | + | | <span><span>0.321</span></span> |
| | + | | <span><span>5%</span></span> |
| | + | | <span><span>0.017</span></span> |
| | + | | <span><span style="display: block; font-family: 'times new roman'; text-align: center;">59</span></span> |
| | |- | | |- |
| | + | | <span><span>'''<span>95% CI:</span>'''</span></span> |
| | + | | |
| | + | | |
| | + | | |
| | + | | <span><span>-26% to 36%</span></span> |
| | + | | <span><span>-0.088 to 0.122</span></span> |
| | + | | <span><span>NNT '''8 to INF NNH = 11 to INF'''</span></span> |
| | |} | | |} |
| | | | |
| − | <span style="font-family: 'Times New Roman';">'''2.''' </span> | + | <span style="font-family: 'Times New Roman';">'''2.'''</span> |
| | | | |
| − | {| | + | {| |
| − | | <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Outcome </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Time to Outcome </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">One HBO session </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Two HBO sessions </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Relative risk reduction </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Absolute risk reduction </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style="font-family: 'Times New Roman';">NNT </span>'''</span></span>
| |
| | |- | | |- |
| − | | <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Recovery </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">1 month </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">0.535 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">0.52 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">3% </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">0.015 </span></span> || <span style'''"display: block; text-align: center;"><span style="display: block; font-family: 'times new roman'; text-align: center;">67 </span></span> | + | | <span><span>'''<span>Outcome</span>'''</span></span> |
| | + | | <span><span>'''<span>Time to Outcome</span>'''</span></span> |
| | + | | <span><span>'''<span>One HBO session</span>'''</span></span> |
| | + | | <span><span>'''<span>Two HBO sessions</span>'''</span></span> |
| | + | | <span><span>'''<span>Relative risk reduction</span>'''</span></span> |
| | + | | <span><span>'''<span>Absolute risk reduction</span>'''</span></span> |
| | + | | <span><span>'''<span style="font-family: 'Times New Roman';">NNT</span>'''</span></span> |
| | |- | | |- |
| − | | <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">95% CI: </span>'''</span></span> || || || || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-20% to 26% </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-0.108 to 0.138 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">NNT ''' 7 to INF NNH = 9 to INF </span></span> | + | | <span><span>'''<span>Recovery</span>'''</span></span> |
| | + | | <span><span>1 month</span></span> |
| | + | | <span><span>0.535</span></span> |
| | + | | <span><span>0.52</span></span> |
| | + | | <span><span>3%</span></span> |
| | + | | <span><span>0.015</span></span> |
| | + | | <span><span style="display: block; font-family: 'times new roman'; text-align: center;">67</span></span> |
| | |- | | |- |
| − | | <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">Severe sequelae or death </span>'''</span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">1 month </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">0.039 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">0.048 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-23% </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-0.009 </span></span> || <span style'''"display: block; text-align: center;"><span style="display: block; font-family: 'times new roman'; text-align: center;">-111 </span></span> | + | | <span><span>'''<span>95% CI:</span>'''</span></span> |
| | + | | |
| | + | | |
| | + | | |
| | + | | <span><span>-20% to 26%</span></span> |
| | + | | <span><span>-0.108 to 0.138</span></span> |
| | + | | <span><span>NNT '''7 to INF NNH = 9 to INF'''</span></span> |
| | |- | | |- |
| − | | <span style'''"display: block; text-align: center;"><span style'''"display: block; text-align: center;">'''<span style'''"font-family: 'Times New Roman';">95% CI: </span>'''</span></span> || || || || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-100% to 100% </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">-0.059 to 0.041 </span></span> || <span style'''"display: block; text-align: center;"><span style'''"display: block; font-family: 'times new roman'; text-align: center;">NNT ''' 24 to INF NNH = 17 to INF </span></span> | + | | <span><span>'''<span>Severe sequelae or death</span>'''</span></span> |
| | + | | <span><span>1 month</span></span> |
| | + | | <span><span>0.039</span></span> |
| | + | | <span><span>0.048</span></span> |
| | + | | <span><span>-23%</span></span> |
| | + | | <span><span>-0.009</span></span> |
| | + | | <span><span style="display: block; font-family: 'times new roman'; text-align: center;">-111</span></span> |
| | |- | | |- |
| | + | | <span><span>'''<span>95% CI:</span>'''</span></span> |
| | + | | |
| | + | | |
| | + | | |
| | + | | <span><span>-100% to 100%</span></span> |
| | + | | <span><span>-0.059 to 0.041</span></span> |
| | + | | <span><span>NNT '''24 to INF NNH = 17 to INF'''</span></span> |
| | |} | | |} |
| | | | |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Comments: </span>'''</span> | + | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Comments:</span>'''</span> <span style="font-family: 'Times New Roman'; font-size: 120%;">1. Many very mildly poisoned patients were included which may bias towards the null. </span> <span style="font-family: 'Times New Roman'; font-size: 120%;">2. Recovery was defined as the absence of any symptoms or signs on questionnaire and examination. </span> <span style="font-family: 'Times New Roman'; font-size: 120%;">3. Best and worst case analysis of missing data does not alter conclusions. </span> <span style="font-family: 'Times New Roman'; font-size: 120%;">4. The indication for HBO in those with a history of loss of consciousness has not been tested in this study.</span> |
| − | <span style="font-family: 'Times New Roman'; font-size: 120%;">1. Many very mildly poisoned patients were included which may bias towards the null. </span> | + | |
| − | <span style="font-family: 'Times New Roman'; font-size: 120%;">2. Recovery was defined as the absence of any symptoms or signs on questionnaire and examination. </span> | + | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Expiry date:</span>''' <font face="times new roman">August 2022</font></span> |
| − | <span style="font-family: 'Times New Roman'; font-size: 120%;">3. Best and worst case analysis of missing data does not alter conclusions. </span> | |
| − | <span style="font-family: 'Times New Roman'; font-size: 120%;">4. The indication for HBO in those with a history of loss of consciousness has not been tested in this study. </span> | |
| | | | |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">Expiry date:</span>''' <span style="font-family: times new roman;">April 2020</span></span> | + | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">References:</span>'''</span> <span style="font-family: 'Times New Roman'; font-size: 120%;">1. Raphael J-C, ElkharratD, Chastang C, Chasles V, Vercken J-B, Gajdos P. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989; 8658:414-419.</span> |
| − | <span style="font-size: 120%;">'''<span style="font-family: 'Times New Roman';">References: </span>'''</span>
| |
| − | <span style="font-family: 'Times New Roman'; font-size: 120%;">1. Raphael J-C, ElkharratD, Chastang C, Chasles V, Vercken J-B, Gajdos P. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989; 8658:414-419. </span> | |
| | | | |
| − | [[File:sumhorsa.gif|center]] | + | [[File:Sumhorsa.gif|center|Sumhorsa.gif]] <span style="display: block; text-align: center;"></span> <span style="display: block; text-align: center;"><span style="color: #8200ff; font-size: 120%;">[[Carbon_monoxide|BACK]]</span></span> |
| − | <span style="display: block; text-align: center;"> | |
| − | </span> | |
| − | <span style="display: block; text-align: center;"><span style="color: #8200ff; font-size: 120%;">[[Carbon monoxide | BACK]]</span></span> | |
The administration of hyperbaric oxygen did not improve outcome in carbon monoxide poisoning without a history of loss of consciousness.
Clinical Bottom Line: 1. No evidence for benefit of hyperbaric oxygen in the treatment of carbon monoxide poisoning without loss of consciousness. 2. No evidence of benefit of two HBO sessions over a single session for patients with a history of loss of consciousness.
Appraised by:Mike Bennett, Dept of Diving and Hyperbaric Medicine, Prince of Wales Hospital Sydney, Saturday, 20 February 1999
Clinical Scenario:A patient presented with carbon monoxide poisoning for treatment. Three-part Question:In patients with mild and moderate carbon monoxide poisoning, does the administration of hyperbaric oxygen, compared to normobaric oxygen, result in any reduction in the rate of neurological impairment one month later? Search Terms:hyperbaric oxygenation, carbon monoxide
The Study: Non-blinded concealed randomised controlled trial with intention-to-treat. Adult patients exposed to carbon monoxide and presenting for treatment within 12 hours of exposure. Minimum carboxyhaemoglobin levels of 10% in smokers and 5% in non-smokers. Control groups1.(N = 170; 148 analysed): Patients with no history of unconsciousness. Normobaric 100% oxygen for six hours. 2.(N = 145; 127 analysed): Patients with a history of loss of consciousness. Oxygen at 2ATA for two hours then 1ATA for 4 hours. Experimental groups 1.(N = 173; 159 analysed): Patients with no history of unconsciousness. Oxygen at 2ATA for two hours then 1ATA for 4 hours. 2.(N = 141; 125 analysed) Patients with a history of loss of consciousness. Oxygen at 2ATA for two hours, then 1ATA for 4 hours, then 2ATA for a further two hours at 12 hours after the first HBO.
The Evidence:1.
| Outcome
|
Time to Outcome
|
Control groups
|
Hyperbaric groups
|
Relative risk reduction
|
Absolute risk reduction
|
NNT
|
| Recovered
|
1 month
|
0.662
|
0.679
|
-3%
|
-0.017
|
-59
|
| 95% CI:
|
|
|
|
-18% to 13%
|
-0.122 to 0.088
|
NNT 11 to INF NNH = 8 to INF
|
| Persistent symptom
|
1 month
|
0.338
|
0.321
|
5%
|
0.017
|
59
|
| 95% CI:
|
|
|
|
-26% to 36%
|
-0.088 to 0.122
|
NNT 8 to INF NNH = 11 to INF
|
2.
| Outcome
|
Time to Outcome
|
One HBO session
|
Two HBO sessions
|
Relative risk reduction
|
Absolute risk reduction
|
NNT
|
| Recovery
|
1 month
|
0.535
|
0.52
|
3%
|
0.015
|
67
|
| 95% CI:
|
|
|
|
-20% to 26%
|
-0.108 to 0.138
|
NNT 7 to INF NNH = 9 to INF
|
| Severe sequelae or death
|
1 month
|
0.039
|
0.048
|
-23%
|
-0.009
|
-111
|
| 95% CI:
|
|
|
|
-100% to 100%
|
-0.059 to 0.041
|
NNT 24 to INF NNH = 17 to INF
|
Comments: 1. Many very mildly poisoned patients were included which may bias towards the null. 2. Recovery was defined as the absence of any symptoms or signs on questionnaire and examination. 3. Best and worst case analysis of missing data does not alter conclusions. 4. The indication for HBO in those with a history of loss of consciousness has not been tested in this study.
Expiry date: August 2022
References: 1. Raphael J-C, ElkharratD, Chastang C, Chasles V, Vercken J-B, Gajdos P. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989; 8658:414-419.
BACK